Xiaoxue Du

ORCID: 0009-0009-3847-9487
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Acupuncture Treatment Research Studies
  • Healthcare and Venom Research
  • Traditional Chinese Medicine Studies
  • Cancer Immunotherapy and Biomarkers
  • Inflammasome and immune disorders
  • interferon and immune responses
  • Cancer-related Molecular Pathways
  • Microtubule and mitosis dynamics
  • HER2/EGFR in Cancer Research
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Thyroid Cancer Diagnosis and Treatment
  • Monoclonal and Polyclonal Antibodies Research
  • Cancer, Stress, Anesthesia, and Immune Response

Harbin Medical University
2023-2024

Fudan University Shanghai Cancer Center
2024

Shanghai Medical College of Fudan University
2024

Third Affiliated Hospital of Harbin Medical University
2023-2024

Abstract Programmed death receptor-1 (PD-1) inhibitors are ineffective against microsatellite-stable (MSS) colorectal cancer. Electroacupuncture (EA) has oncosuppressive and immunomodulatory properties. Here, we investigated the antitumor effects of EA explored feasibility combined with anti–PD-1 in MSS Results showed that exerted its effect an intensity-specific manner, moderate-intensity (1.0 mA) induced maximal tumor inhibition. enhanced immune responses by increasing lymphocytes granzyme...

10.1158/2326-6066.cir-23-0309 article EN Cancer Immunology Research 2023-11-13

Background and Aims: HCC, particularly the multifocal features aggressive invasion dismal prognosis. Locoregional treatments were often refractory to eliminate tumor tissue, resulting in residual cells persisting subsequent progression. Owing problematic delivery systemic therapies, such as lenvatinib (LEN) therapy, show limited clinical benefit preventing Therefore, more advanced strategies for postablative HCC are urgently needed. Approach Results: Motivated by chemotaxis penetration of...

10.1097/hep.0000000000000903 article EN Hepatology 2024-04-29

<div>Abstract<p>Programmed death receptor-1 (PD-1) inhibitors are ineffective against microsatellite-stable (MSS) colorectal cancer. Electroacupuncture (EA) has oncosuppressive and immunomodulatory properties. Here, we investigated the antitumor effects of EA explored feasibility combined with anti–PD-1 in MSS Results showed that exerted its effect an intensity-specific manner, moderate-intensity (1.0 mA) induced maximal tumor inhibition. enhanced immune responses by increasing...

10.1158/2326-6066.c.7005676.v1 preprint EN 2024-01-03

<div>Abstract<p>Programmed death receptor-1 (PD-1) inhibitors are ineffective against microsatellite-stable (MSS) colorectal cancer. Electroacupuncture (EA) has oncosuppressive and immunomodulatory properties. Here, we investigated the antitumor effects of EA explored feasibility combined with anti–PD-1 in MSS Results showed that exerted its effect an intensity-specific manner, moderate-intensity (1.0 mA) induced maximal tumor inhibition. enhanced immune responses by increasing...

10.1158/2326-6066.c.7005676 preprint EN 2024-01-03

Anaplastic thyroid cancer (ATC) is the most lethal tumor arising from follicular epithelium. Lenvatinib an off-label use option for ATC patients in many countries but approved prescription Japan. However, lenvatinib resistance a substantial clinical challenge. Clinical samples including lenvatinib-resistant tumors are used to build patient-derived cells and xenografts. High-throughput drug screening synergy analyses performed identify effective combination partner lenvatinib. Cellular...

10.1002/advs.202413514 article EN cc-by Advanced Science 2024-12-24
Coming Soon ...